Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia

NCT00660036 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped due to new safety information

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Gemtuzumab ozogamicin
DRUG: Mitoxantrone
DRUG: Etoposide

Sponsor

University of Pittsburgh